Published in
American Association for the Advancement of Science, Science Translational Medicine, 542(12), 2020
DOI: 10.1126/scitranslmed.aay8314
Links
Tools
Preclinical validation of a repurposed metal chelator as an early-intervention therapeutic for hemotoxic snakebite
Journal article published in 2020 by
Laura-Oana Albulescu 
,
Melissa S. Hale ,
Stuart Ainsworth ,
Jaffer Alsolaiss,
Edouard Crittenden ,
Juan J. Calvete ,
Chloe Evans ,
Mark C. Wilkinson,
Robert A. Harrison ,
Jeroen Kool,
Nicholas R. Casewell
,
Melissa S. Hale ,
Stuart Ainsworth ,
Jaffer Alsolaiss,
Edouard Crittenden ,
Juan J. Calvete ,
Chloe Evans ,
Mark C. Wilkinson,
Robert A. Harrison ,
Jeroen Kool,
Nicholas R. Casewell
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 
Abstract
DMPS, a drug licensed to treat mercury poisoning, is preclinically effective as an oral therapeutic for treating certain hemotoxic snakebites.